Freedom of Information responses from the MHRA - week commencing 2 January 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 2 January 2023.
- From:
- Medicines and Healthcare products Regulatory Agency
- Published
- 14 March 2024
Documents
FOI 22/1137
PDF, 41.9 KB, 1 page
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1137 attachment
PDF, 295 KB, 50 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1151
PDF, 66.1 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1161
PDF, 91.9 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1172
PDF, 118 KB, 3 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1178
PDF, 133 KB, 3 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1190
PDF, 90.4 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1197
PDF, 69.6 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1206
PDF, 94 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1206 attachment
PDF, 2.19 MB, 102 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1220
PDF, 75.5 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
FOI 22/1221
PDF, 123 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Details
The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 2 January 2023.